Low-Dose Decitabine Augments the Activation and Anti-Tumor Immune Response of IFN-γ+ CD4+ T Cells Through Enhancing IκBα Degradation and NF-κB ActivationXiang Li, Jing Nie|Frontiers in Cell and Developmental Biology|2021Cited by 14